21 March 2017
At the company’s Annual General Meeting held today, the following resolutions were passed:
The Board of Directors' proposal regarding remuneration of the Board of Directors for 2016 and 2017 was adopted, with the amendment that payment of the part of the remuneration being linked to the making of a take-over offer on the company is subject to such offer being accepted by 50% of the share capital of the company.
Karin Garre Allan Andersen
Chairman of the Board of Directors CEO
Allan Andersen, CEO, mobile phone +45 4016 3864.
NeuroSearch A/S (NEUR) is listed on Nasdaq Copenhagen A/S.